KNAW

Research

Evaluation of (neuro)toxicity of systemic anti-cancer therapy and neuroprotection

Pagina-navigatie:


Update content


Title Evaluation of (neuro)toxicity of systemic anti-cancer therapy and neuroprotection
Period 01 / 2011 - unknown
Status Current
Research number OND1345906
Data Supplier VUmc CCA

Abstract

Peripheral neurotoxicity is a serious side effect of several chemotherapeutic agents, which can be dose-limiting. This project focuses on clinical aspects of chemotherapy-induced neurotoxicity. Quality of life aspects of peripheral neurotoxicity are investigated in collaboration with the EORTC: a sub-module of the EORTC Quality of Life scale (the QLQ-CIPN20 ) has been developed in cooperation with several foreign centers. The questionnaire has been field tested. International collaboration has been undertaken to develop guidelines for the most optimal assessment of chemotherapy-induced peripheral neuropathy, the Ci-PERINOMS study.

Related organisations

Related people

Researcher Dr. T.J. Postma
Project leader Prof.dr. J.J. Heimans

Go to page top
Go back to contents
Go back to site navigation